Intimation under Regulation30 & 51 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Environmental, Social and Governance Rating
Awaiting price reaction for this filing.
Mankind Pharma has disclosed that ISS ESG, an external ratings agency, has issued an ESG (Environmental, Social and Governance) Corporate Rating Report for the company on June 3, 2025. The rating was prepared on a voluntary basis using only publicly available data, and the company itself has not verified the underlying information. Mankind Pharma has been assigned an overall ESG score of 38.98, placing it in the 'C-' rating category. The filing has been made to the stock exchanges purely as a regulatory disclosure under SEBI's listing rules.
A 'C-' ESG rating with a score below 40 is on the lower end of the scale and may be viewed negatively by ESG-focused institutional investors and funds that screen companies on sustainability criteria. However, since this is a third-party rating based on public data that the company has not validated, it is unlikely to have an immediate direct impact on the stock price or business operations.